Applied StemCell
Milpitas, CA
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-02
60.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (3)
○ EMA GMP
○ MHRA GMP
Quick Facts: Applied StemCell
- Signal Score
- 60.5/100 (as of 2026-04-02)
- Quality Compliance
- Assessment pending
- Headquarters
- Milpitas, CA
- Modalities
- Cell Therapy, Gene Editing
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy, Gene Editing
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
63.0
Active fundraising/financial news (3 articles)
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Active fundraising/financial news (3 articles)
Capacity
58.0
1 manufacturing site: Milpitas, CA
Modalities: Cell Therapy, Gene Editing
Capacity assessment: 58.0/100
Sites: Milpitas, CA
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
Recent Press3 articles
1 manufacturing site: Milpitas, CA
Modalities: Cell Therapy, Gene Editing
Capacity assessment: 58.0/100
Recent News 3 articles
Applied StemCell and Cellipont Bioservices Partner to Offer - GlobeNewswire
Applied StemCell and Cellipont Bioservices Partner to Offer GlobeNewswire
Applied StemCell and Cellipont Bioservices Partner to Offer a Seamless Path for iPSC-Derived Cell Therapy Development - The Manila Times
Applied StemCell and Cellipont Bioservices Partner to Offer a Seamless Path for iPSC-Derived Cell Therapy Development The Manila Times
Applied StemCell and Cellipont Bioservices Partner to Offer - GlobeNewswire
Applied StemCell and Cellipont Bioservices Partner to Offer GlobeNewswire
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
Bayer (Cell Therapy Mfg)
Berkeley, CA
Signal Score: 83.8
Cell Therapy, Gene Editing
Cedars-Sinai Biomanufacturing
Los Angeles, CA
Signal Score: 78.9
Cell Therapy, Gene Editing
Green Phoenix Labs
San Diego, CA
Signal Score: 78.1
Cell Therapy, Gene Editing
Poseida Therapeutics (CDMO)
San Diego, CA
Signal Score: 58.7
CAR-T, Cell Therapy, Gene Editing